Krishana Phoschem's Bank Facilities Rated Crisil A+/Stable and Crisil A1 by CRISIL
Krishana Phoschem Limited's bank facilities have been reaffirmed with a CRISIL A+/Stable long-term rating and CRISIL A1 short-term rating by CRISIL. The total rated bank loan facilities amount to ₹1125 Crore. The ratings were removed from 'Rating Watch with Developing Implications'.
A stable credit rating is important for a company's borrowing capacity and cost of debt. This reaffirmation is positive but does not represent a significant new development or a drastic change in financial performance, hence the medium impact.
The reaffirmation of credit ratings by CRISIL, especially with a stable outlook and removal from a watch status, indicates a positive assessment of the company's financial health and its ability to meet its obligations.
Krishana Phoschem Limited has announced that CRISIL Ratings Limited has assigned and reaffirmed the credit ratings for the company's bank facilities. The long-term rating has been assigned a CRISIL A+/Stable, and it has been removed from 'Rating Watch with Developing Implications'. The short-term rating has been assigned a CRISIL A1, also removed from 'Rating Watch with Developing Implications'.
The total bank loan facilities rated amount to ₹1125 Crore. These include various credit facilities such as cash credit, letters of credit, and loan equivalent risk limits across multiple banks including ICICI Bank, RBL Bank, State Bank of India, YES Bank, Axis Bank, and The Federal Bank. Additionally, proposed fund-based bank limits and term loans from Shinhan Bank and Axis Bank have also been rated.
The rating reaffirmation indicates CRISIL's current opinion on the likelihood of timely payment of obligations under the rated instruments. The company has been informed of these ratings on October 8, 2026, with the rating action taken by CRISIL on October 7, 2026.
What to do with a filing like this
Krishana Phoschem Limited filed this with the NSE as a statutory disclosure, categorised under credit ratings. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krishana Phoschem Limited. Read the original for the full detail.